Discover the Doptelet Copay
Assistance Program

Eligible commercially insured patients may qualify for the Doptelet Copay Assistance Program

What's the program?

Eligible patients may pay as little as $0 for each Doptelet prescription
Annual maximum benefit up to $15,000

Eligible patients must:

Have commercial insurance that covers Doptelet
Not be enrolled in any state or federal healthcare program such as Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD), or TRICARE
Be ≥1 years of age or older
Be a resident in the United States or a US Territory

How to enroll:

Approved pharmacies, healthcare professionals, and Doptelet Connect can enroll patients
Patients can enroll themselves as well as their caregivers
Please call 1-833-368-2663 Monday–Friday 8am–7pm ET for more information

Terms and Conditions

Patients pay as little as $0 per prescription. Copay Assistance Program has an annual calendar cap of $15,000
The Copay Assistance Program is void where prohibited by law, taxes, or restricted
This offer is non-transferable, no substitutions are permissible, and this offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
Sobi, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice
The Copay Assistance Program for Doptelet is not insurance and is not intended to substitute for insurance
Patients, pharmacists, and healthcare providers must not seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this Copay Assistance Program. Patients must not seek reimbursement from any health savings, flexible spending, or other healthcare reimbursement accounts for the amount of assistance received from the Copay Assistance Program
Certain information pertaining to your use of the Copay Assistance Program will be shared with Sobi, Inc., the sponsor of the Copay Assistance Program. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your copay that will be paid for by using this Copay Assistance Program. For more information, please see the Sobi Privacy Policy at https://sobi-northamerica.com/privacy-policy
Acceptance in this Copay Assistance Program is not conditioned on any past, present, or future purchase, including additional doses
Enrollment for the Copay Assistance Program is valid through the calendar year
Sobi reserves the right to change program terms at any time

ABOUT PERSISTENT & CHRONIC ITP

Understanding your child’s ITP diagnosis is important. Learn about the causes of this rare platelet disorder in children and explore potential treatment approaches.

What are the common signs and symptoms of ITP?

ITP is known as a heterogeneous disease, which means your child may experience different signs and symptoms than someone else with ITP.

A sign is something that your child’s healthcare team can observe or measure, such as their platelet counts. Symptoms are the feelings and concerns that your child experiences, such as fatigue. Most people with ITP have platelet counts under 100,000 per microliter, but those counts vary from person to person, and your child may find their platelet counts are unpredictable at times. The lower their platelet count, the greater the risk of ITP symptoms.

Here are some common signs and symptoms of ITP:

Fatigue

Your child may feel exhausted and unable to keep up with everyday activities to the point where they may feel tired even after getting a full night’s sleep.

Bruising

Your child may notice their skin start to bruise very easily, even spontaneously, from damaged blood vessels under the skin. Bruising may happen even if they don’t remember injuring themselves.

Petechiae/Purpura

Your child may see small red or purple spots start to appear from broken blood vessels on areas like their upper arms or lower legs.

ITP Bleeding

Your child may experience bleeding from their gums and nose, have an unusually heavy menstrual flow, or notice cuts bleeding for longer periods of time. They may also see blood in their urine, vomit, or stool.

These are not all the signs and symptoms of ITP. It is important to discuss your signs and symptoms with your doctor as only a doctor can diagnose ITP. Doptelet and Doptelet Sprinkle are not approved to treat these symptoms.

How is persistent and chronic ITP treated in children?

There are a few options for treating persistent and chronic ITP, such as corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and TPO-RAs that offer different benefits and risks. Click on each of these common treatment options to learn how they work.

Corticosteroids are immunosuppressants that can work by reducing inflammation and the overall activity of your child’s immune system. For ITP, they are commonly prescribed right after diagnosis and are intended for short-term use to stop the body from destroying platelets.

While steroids can be effective, continued use, especially at high doses, may have side effects such as increased weight gain, swelling of the face, sleep problems, and mood disturbances such as irritability. Steroids may also come with increased risk of infections, diabetes, cataracts, liver issues, high blood pressure, high blood sugar, osteoporosis, and bone and muscle disorders.

For these reasons, the experts who wrote the current American Society of Hematology (ASH) ITP guidelines recommend limiting steroid treatment to less than 6 weeks.

Ask your child’s doctor for more information about the ASH Guidelines.

IVIG is an immune-modulating therapy made of antibodies that can help regulate your child’s immune system. IVIG is a first-line treatment typically used in emergency, short-term situations when platelet counts are severely low. IVIG can work by reducing certain immune responses that may be responsible for destroying platelets, but unlike immunosuppressants, it does not weaken the entire immune system.

Rituximab is an immunosuppressant. Like steroids, it can work to reduce the overall activity of your child’s immune system to stop their body from destroying platelets. Because rituximab changes how the immune system works, it may be easier for your child to get sick or develop other conditions.

Talk to your child’s doctor about what treatment may be right for them. If other therapies aren’t working for your child and their platelet counts don’t stay lifted, their doctor may consider a thrombopoietin receptor agonist (TPO-RA), such as Doptelet or Doptelet Sprinkle.

Treating with Doptelet and Doptelet Sprinkle, medicines called TPO-RAs

Doptelet and Doptelet Sprinkle are TPO-RAs, which are a type of medication that mimics the body’s natural process of creating platelets. Doptelet and Doptelet Sprinkle can help boost the pathway responsible for making platelets, which adds to the platelets your child’s body is already making. This ultimately can increase their overall count. Doptelet tablets and Doptelet Sprinkle are not used to make platelet counts normal.

Neither Doptelet nor Doptelet Sprinkle requires weekly doctor’s appointments for treatment injections or becomes less effective when your child eats certain foods, like ice cream. Doptelet as a tablet must be taken with food. Doptelet Sprinkle oral granules must be mixed with a soft food or liquid like applesauce or orange juice. See the Instructions for Use for a full list of recommended soft foods and liquids. Work with the doctor to determine a dosing schedule that works best for you and your child. The doctor may also adjust their dose based on other medications your child takes and their platelet counts.

Your child’s doctor will check their platelet count before, during, and for at least 4 weeks after stopping their treatment with Doptelet or Doptelet Sprinkle.

Find a persistent or chronic ITP specialist near you

One of the most important steps to getting the care your child deserves is finding the right provider in your area.

Find a specialist

Sobi is not responsible for the choices or actions that you or others take because of information provided by this free tool.

Indication & Important Safety Information

What are DOPTELET (avatrombopag) and DOPTELET Sprinkle (avatrombopag)?

DOPTELET is a prescription medicine used to treat low blood platelet counts in:

Adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure
Adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Children 1 year and older with persistent or chronic ITP when other treatments have not worked well enough

DOPTELET tablets and DOPTELET Sprinkle are different dosage forms of DOPTELET.

DOPTELET and DOPTELET Sprinkle are not used to make platelet counts normal.

It is not known if DOPTELET or DOPTELET Sprinkle are safe and effective in children younger than 1 year of age.

IMPORTANT SAFETY INFORMATION

Before you take DOPTELET or DOPTELET Sprinkle, tell your doctor about all your medical conditions, including if you:

Have ever had a blood clot
Are pregnant or plan to become pregnant. DOPTELET or DOPTELET Sprinkle may harm your unborn baby. Tell your healthcare provider if you become pregnant or think you may be pregnant during treatment with DOPTELET or DOPTELET Sprinkle
Are breastfeeding or plan to breastfeed. It is not known if DOPTELET or DOPTELET Sprinkle passes into your breast milk. Do not breastfeed during your treatment with DOPTELET and DOPTELET Sprinkle for at least 2 weeks after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. DOPTELET or DOPTELET Sprinkle may affect the way other medicines work, and other medicines may affect the way DOPTELET or DOPTELET Sprinkle works.

What are the side effects of DOPTELET or DOPTELET Sprinkle?

DOPTELET or DOPTELET Sprinkle may cause serious side effects including blood clots. People with CLD or persistent or chronic ITP and people with certain blood clotting conditions may have an increased risk of developing blood clots. Tell your healthcare provider right away if you get signs and symptoms of a blood clot, including:

Swelling, pain, or tenderness in your legs
Shortness of breath
Chest pain

Fast heartbeat
Stomach (abdominal) pain or tenderness

The most common side effects of DOPTELET in adults with CLD are fever, stomach (abdominal) pain, nausea, headache, tiredness, and swelling of hands and feet.

The most common side effects of DOPTELET in adults with chronic ITP are headache, tiredness, bruising, nosebleed, upper respiratory infection, joint pain, bleeding gums, purple or red spots on your skin, and runny nose.

The most common side effects of DOPTELET or DOPTELET Sprinkle in children with persistent or chronic ITP are viral infection, runny nose, cough, fever, and pain in the mouth or throat.

These are not all of the possible side effects of DOPTELET or DOPTELET Sprinkle. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the DOPTELET and DOPTELET Sprinkle full Prescribing Information.

Indication & Important Safety Information

What are DOPTELET (avatrombopag) and DOPTELET Sprinkle (avatrombopag)?

DOPTELET is a prescription medicine used to treat low blood platelet counts in:

Adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure
Adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Children 1 year and older with persistent or chronic ITP when other treatments have not worked well enough

What are DOPTELET (avatrombopag) and DOPTELET Sprinkle (avatrombopag)?

DOPTELET is a prescription medicine used to treat low blood platelet counts in:

Adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure
Adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Children 1 year and older with persistent or chronic ITP when other treatments have not worked well enough

DOPTELET tablets and DOPTELET Sprinkle are different dosage forms of DOPTELET.

DOPTELET and DOPTELET Sprinkle are not used to make platelet counts normal.

It is not known if DOPTELET or DOPTELET Sprinkle are safe and effective in children younger than 1 year of age.

IMPORTANT SAFETY INFORMATION

Before you take DOPTELET or DOPTELET Sprinkle, tell your doctor about all your medical conditions, including if you:

Have ever had a blood clot
Are pregnant or plan to become pregnant. DOPTELET or DOPTELET Sprinkle may harm your unborn baby. Tell your healthcare provider if you become pregnant or think you may be pregnant during treatment with DOPTELET or DOPTELET Sprinkle
Are breastfeeding or plan to breastfeed. It is not known if DOPTELET or DOPTELET Sprinkle passes into your breast milk. Do not breastfeed during your treatment with DOPTELET and DOPTELET Sprinkle for at least 2 weeks after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time

What are the side effects of DOPTELET or DOPTELET Sprinkle?

Swelling, pain, or tenderness in your legs
Shortness of breath
Chest pain

Fast heartbeat
Stomach (abdominal) pain or tenderness

The most common side effects of DOPTELET in adults with CLD are fever, stomach (abdominal) pain, nausea, headache, tiredness, and swelling of hands and feet.

The most common side effects of DOPTELET or DOPTELET Sprinkle in children with persistent or chronic ITP are viral infection, runny nose, cough, fever, and pain in the mouth or throat.

These are not all of the possible side effects of DOPTELET or DOPTELET Sprinkle. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the DOPTELET and DOPTELET Sprinkle full Prescribing Information.